Envoy Medical Inc Revenue Growth Rates (COCH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Envoy Medical Inc   (NASDAQ: COCH)
 

COCH's Revenue Growth by Quarter and Year

Envoy Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/COCH/growth
https://api.csimarket.com/api/v1/companies/COCH/fundamentals
https://api.csimarket.com/api/v1/companies/COCH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
COCH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.07
2nd Quarter June 0.05
1st Quarter March 0.04
FY 0.16





COCH Revenue third quarter 2026 Y/Y Growth Comment
Envoy Medical Inc achieved in the third quarter 2026, above Company average Revenue rise of 65% year on year, to $ 0.07 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 114 other companies have achieved higher Revenue growth. While Envoy Medical Inc ' s Revenue jump of 65% ranks overall at the positon no. 2109 in the third quarter 2026.


COCH Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 65 %
2nd Quarter June -37.5 %
1st Quarter March -20 %
FY   -

Financial Statements
Envoy Medical Inc 's third quarter 2026 Revenue $ 0.07 millions COCH's Income Statement
Envoy Medical Inc 's third quarter 2025 Revenue $ 0.04 millions Quarterly COCH's Income Statement


COCH Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 32 %
2nd Quarter June 25 %
1st Quarter March -50 %
FY (Year on Year)   -


Back to COCH Growth rate Comparisons >> Back to COCH Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #115
Healthcare Sector #314
Overall #2109

Revenue Y/Y Growth Statistics
High Average Low
38.53 % -4.94 % -28.8 %
(Jun 30 2024)   (Dec 31 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #115
Healthcare Sector #314
Overall #2109
Revenue Y/Y Growth Statistics
High Average Low
38.53 % -4.94 % -28.8 %
(Jun 30 2024)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Envoy Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
290 % 18.71 % -64.91 %
(Mar 31 2023)  


COCH's III. Quarter Q/Q Revenue Comment
Envoy Medical Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 32%, to $ 0.07 millions, from $0.05 millions in the second quarter.
COCH is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Envoy Medical Inc 's Revenue growth quarter on quarter, overall rank is 429.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #94
Overall #429
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #24
Healthcare Sector #94
Overall #429
Revenue Q/Q Growth Statistics
High Average Low
290 % 18.71 % -64.91 %
(Mar 31 2023)  


COCH's III. Quarter Q/Q Revenue Comment
Envoy Medical Inc achieved in the III. Quarter 2026 above company average sequential Revenue jump of 32%, to $ 0.07 millions, from $0.05 millions in the second quarter.
COCH is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 23 other companies have achieved higher Revenue quarter on quarter growth. While Envoy Medical Inc 's Revenue growth quarter on quarter, overall rank is 429.


Envoy Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.21
Y / Y Revenue Growth (TTM) -6.76 %
Year on Year Revenue Growth Overall Ranking # 3492
Seqeuential Revenue Change (TTM) -11.54 %
Seq. Revenue Growth (TTM) Overall Ranking # 2109


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Envoy Medical Inc reported a decrease in Revenue by -6.76% year on year, to $0 millions, compare to the 10.38% growth at Mar 31 2026.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3050 to 3492.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 469
Overall # 3492

Revenue TTM Y/Y Growth Statistics
High Average Low
38.53 %
 -4.94 %
-28.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 314
S&P 500 # 2109
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Envoy Medical Inc reported a decrease in Revenue by -6.76% year on year, to $0 millions, compare to the 10.38% growth at Mar 31 2026.

In the Healthcare sector 468 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3050 to 3492.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 115
Healthcare Sector # 469
Overall # 3492

Revenue TTM Y/Y Growth Statistics
High Average Low
38.53 %
-4.94 %
-28.8 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 115
Sector # 314
S&P 500 # 2109




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
COCH's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Verastem Inc 113.59%$ 113.592 millions
Hyperfine Inc 109.27%$ 109.270 millions
Pelthos Therapeutics Inc 107.87%$ 107.872 millions
Co diagnostics Inc 94.58%$ 94.580 millions
Autolus Therapeutics Plc94.57%$ 94.574 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________93.02%$ 93.022 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions


About Envoy Medical Inc Revenue Growth Rates (COCH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Envoy Medical Inc (CIK 1840877).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-116117
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Envoy Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.